Immunitor Completes Business Trip to China and Presents at Chinese Academy of Science Annual TB Meeting
13 déc. 2010 10h10 HE
|
Immune Network Ltd
VANCOUVER, British Columbia, Dec. 13, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has concluded a successful business trip to China and presented new...
Immunitor Awarded the Key U.S. Patent Related to Oral Vaccine Technology Platform
29 nov. 2010 07h38 HE
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the...
Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5
14 nov. 2010 23h21 HE
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 14, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that its potential acquisition, Immunitor USA Inc., has announced the completion of...
Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week
01 nov. 2010 09h42 HE
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 1, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), a company in the business of discovery and development of immune-based therapies, today announced...
Immunitor Therapy is a Potential Breakthrough Against Tuberculosis
25 oct. 2010 07h29 HE
|
Immune Network Ltd
VANCOUVER, Canada, Oct. 25, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that a clinical trial of V5 Immunitor oral vaccine was published earlier this month demonstrating...
Immune Network Ltd. Announces Intent to Acquire Oral Vaccine Technology Platform
16 sept. 2010 09h58 HE
|
Immune Network Ltd
VANCOUVER, B.C., Sept. 16, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises the Company has a plan to acquire patented oral vaccine technology developed and clinically...
Advectus and Immune Announce Nano-Pharmaceutical Project Update
04 sept. 2003 18h20 HE
|
Immune Network Ltd
VANCOUVER, B.C., Sept. 4, 2003 (PRIMEZONE) -- Advectus Life Sciences Inc. (TSX Venture Exchange:AVX) (Other OTC:AVXSF) announced today that it has acquired an option from Immune Network Ltd. (Pink...